User profiles for Eltahir A. Khalil
 | Eltahir Awad Gasim KhalilProfessor of Haematology/immunohaematology, University of Khartoum, Sudan Verified email at iend.org Cited by 6500 |
First generation leishmaniasis vaccines: a review of field efficacy trials
First generation candidate vaccines against leishmaniasis, prepared using inactivated whole
parasites as their main ingredient, were considered as promising because of their relative …
parasites as their main ingredient, were considered as promising because of their relative …
[HTML][HTML] Safety and efficacy of single dose versus multiple doses of AmBisome® for treatment of visceral leishmaniasis in eastern Africa: a randomised trial
EAG Khalil, T Weldegebreal, BM Younis… - PLoS neglected …, 2014 - journals.plos.org
Background Anti-leishmanial drug regimens that include a single dose AmBisome® could
be suitable for eastern African patients with symptomatic visceral leishmaniasis (VL) but the …
be suitable for eastern African patients with symptomatic visceral leishmaniasis (VL) but the …
Paromomycin and miltefosine combination as an alternative to treat patients with visceral leishmaniasis in eastern Africa: A randomized, controlled, multicountry trial
…, A Ismail Omer Haroun, EAG Khalil… - Clinical Infectious …, 2023 - academic.oup.com
Background This study aimed to determine whether paromomycin plus miltefosine (PM/MF)
is noninferior to sodium stibogluconate plus paromomycin (SSG/PM) for treatment of primary …
is noninferior to sodium stibogluconate plus paromomycin (SSG/PM) for treatment of primary …
[HTML][HTML] Safety and effectiveness of sodium stibogluconate and paromomycin combination for the treatment of visceral leishmaniasis in eastern Africa: results from a …
Introduction In 2010, WHO recommended a new first-line treatment for visceral
leishmaniasis (VL) in Eastern Africa. The new treatment, a combination of intravenous (IV) or …
leishmaniasis (VL) in Eastern Africa. The new treatment, a combination of intravenous (IV) or …
[HTML][HTML] Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan
Post-kala-azar dermal leishmaniasis (PKDL) is a chronic, stigmatizing skin condition occurring
frequently after apparent clinical cure from visceral leishmaniasis. Given an urgent need …
frequently after apparent clinical cure from visceral leishmaniasis. Given an urgent need …
[HTML][HTML] Y chromosome lineage-and village-specific genes on chromosomes 1p22 and 6q27 control visceral leishmaniasis in Sudan
Familial clustering and ethnic differences suggest that visceral leishmaniasis caused by
Leishmania donovani is under genetic control. A recent genome scan provided evidence for a …
Leishmania donovani is under genetic control. A recent genome scan provided evidence for a …
[HTML][HTML] Anti-plasmodial effects of Azadirachta indica in experimental cerebral malaria: Apoptosis of cerebellar Purkinje cells of mice as a marker
Background: Malaria is a major public health problem in the world, but treatment of malaria
is becoming more difficult due to increasing drug resistance. Therefore, the need for …
is becoming more difficult due to increasing drug resistance. Therefore, the need for …
[HTML][HTML] Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral …
Background Treatment options for Visceral Leishmaniasis (VL) in East Africa are far from
satisfactory due to cost, toxicity, prolonged treatment duration or emergence of parasite …
satisfactory due to cost, toxicity, prolonged treatment duration or emergence of parasite …
[HTML][HTML] The economic burden of visceral leishmaniasis in Sudan: an assessment of provider and household costs
…, BM Younis, M Balasegaram, EAG Khalil… - The American Journal …, 2013 - ncbi.nlm.nih.gov
Visceral leishmaniasis (VL) is a neglected parasitic disease that is fatal if left untreated and
is endemic in eastern Sudan. We estimated the direct and indirect costs of treatment of VL …
is endemic in eastern Sudan. We estimated the direct and indirect costs of treatment of VL …
Aflatoxin M1 in breast milk of nursing Sudanese mothers
…, SYA Adam, NAM Ahmed, AAA Khairy, EAG Khalil - Mycotoxin …, 2012 - Springer
The presence of aflatoxin M 1 (AFM 1 ) in the breast milk of nursing Sudanese mothers was
investigated using AOAC official method 980.21 as the extraction method and HPLC with …
investigated using AOAC official method 980.21 as the extraction method and HPLC with …